MX9306295A - Composiciones farmaceuticas para tratar sintomas de resfriado. - Google Patents

Composiciones farmaceuticas para tratar sintomas de resfriado.

Info

Publication number
MX9306295A
MX9306295A MX9306295A MX9306295A MX9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A
Authority
MX
Mexico
Prior art keywords
cold
pharmaceutical compositions
treat symptoms
symptoms
treat
Prior art date
Application number
MX9306295A
Other languages
English (en)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9306295A publication Critical patent/MX9306295A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composición farmacéutica para tratar síntomas de resfriado caracterizada porque comprende un compuesto activo y 3-1-mentoxipropano-1,2-diol.
MX9306295A 1992-10-09 1993-10-08 Composiciones farmaceuticas para tratar sintomas de resfriado. MX9306295A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95501392A 1992-10-09 1992-10-09

Publications (1)

Publication Number Publication Date
MX9306295A true MX9306295A (es) 1994-04-29

Family

ID=25496254

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306295A MX9306295A (es) 1992-10-09 1993-10-08 Composiciones farmaceuticas para tratar sintomas de resfriado.

Country Status (7)

Country Link
EP (1) EP0662840A1 (es)
JP (1) JPH08502288A (es)
AU (1) AU678561B2 (es)
CA (1) CA2146637C (es)
MX (1) MX9306295A (es)
NZ (1) NZ256346A (es)
WO (1) WO1994008551A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2160874C (en) * 1993-04-30 1999-05-11 William Fletcher Beck Nasal aromatic releasing compositions
AU1716995A (en) * 1994-03-18 1995-10-09 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
US5698181A (en) * 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
CA2277911C (en) * 1997-01-13 2010-09-14 Emory University Compounds and their combinations for the treatment of influenza infection
GB9707978D0 (en) * 1997-04-21 1997-06-11 Procter & Gamble Throat soothing compositions
GB9707977D0 (en) * 1997-04-21 1997-06-11 Procter & Gamble Centre filled confectionery
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
WO2003020258A1 (fr) * 2001-09-04 2003-03-13 Boehringer Ingelheim International Gmbh Medicament contre la grippe de type a
EP1494654B1 (en) 2002-04-04 2008-03-12 Pfizer Products Inc. Palatable chewable tablet
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20090203776A1 (en) * 2004-09-23 2009-08-13 Matias Jonathan R Methods of using menthol propyleneglycol-carbonate and analogs thereof for producing anti-inflammatory and anti-angiogenic effects
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
AU2016219620B2 (en) * 2006-04-21 2017-05-11 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
WO2012104569A1 (en) 2011-02-02 2012-08-09 GILHOLM, Stephen, Philip Composition of monoterpenoids for the treatment of cancer
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
WO2019222100A1 (en) 2018-05-16 2019-11-21 Zumeta Perez Javier High concentration suspension formulation for cold and flu soft gel capsule medications
CN112972439A (zh) * 2019-12-16 2021-06-18 南京亿华药业有限公司 一种愈美泡腾片及其制备方法
EP4099977A1 (en) 2020-02-03 2022-12-14 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
ATE128351T1 (de) * 1991-04-04 1995-10-15 Procter & Gamble Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.

Also Published As

Publication number Publication date
AU678561B2 (en) 1997-06-05
WO1994008551A3 (en) 1994-06-23
AU4930793A (en) 1994-05-09
EP0662840A1 (en) 1995-07-19
CA2146637C (en) 2001-02-13
JPH08502288A (ja) 1996-03-12
WO1994008551A2 (en) 1994-04-28
NZ256346A (en) 1997-04-24

Similar Documents

Publication Publication Date Title
MX9306295A (es) Composiciones farmaceuticas para tratar sintomas de resfriado.
ES2196160T3 (es) Uso de una combinacion de tensioactivos, agentes quelantes y aceites esenciales para desinfeccion efectiva.
FI973492A (fi) NO-syntaasin estäjät
TR200102647T2 (tr) Doğurganlığı geliştirmeye mahsus bileşimler
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
DE69805983D1 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
PT752813E (pt) Inibidores de proteases de parasitas metazoarios
MX9505181A (es) Utilizacion de un antagonista de la substancia p en una composicion farmaceutica para tratar desordenes de la piel de origen neurogenico.
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
ID24184A (id) Obat untuk perawatan disfungsi ereksi
ES2146249T3 (es) Composicion farmaceutica para tratar la impotencia que contiene un inhibidor alfa-1 y un inhibidor alfa-2.
FI962369A0 (fi) Farmaseuttinen formulointi myrkytyksen ehkäisemiseksi tai esihoidoksi organofosforisilla koliiniesteraasi-inhibiittoreilla
PT1054681E (pt) Utilizacao de combinacoes de agentes activos consistindo de antibioticos e extractos vegetais contendo terfeno na medicina veterinaria
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE200026T1 (de) Behandlung von laminitis
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
DE69114922D1 (de) Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten.
BR9608721A (pt) Composição farmacêutica, e, processo para tratar inflamação
UY24181A1 (es) Método para tratar un infarto de miocardio agudo con hirudina y ácido acetilsalicílico en pacientes no sometidos a tratamiento trombolítico
ES2044534T3 (es) Un metodo para la preparacion de una composicion tromboliticamente activa.
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees